2 studies found for:    mdx-1106 hcv
Show Display Options
Rank Status Study
1 Completed A Study of MDX-1106 to Treat Patients With Hepatitis C Infection
Condition: Hepatitis C
Interventions: Drug: MDX1106-02;   Drug: Placebo
2 Recruiting Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab and the Combination Nivolumab Plus Ipilimumab in Subjects With Advanced Liver Cancer
Condition: Hepatocellular Carcinoma
Interventions: Biological: Nivolumab;   Drug: Sorafenib;   Drug: Ipilimumab

Indicates status has not been verified in more than two years